<p>IRVINE, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON, AEON WS), a clinical-stage biopharmaceutical company focused on developing a
<p>The volatile risk sentiment last week changed to somewhat more consolidation this week. Incoming GDP figures from the euro area and the US naturally both pointed to a dismal first quarter, bu
Leave a Comment